Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

Clinical trial NCT04748185 · COMPLETED

Trial details

NCT number: NCT04748185
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma B-cell Non Hodgkin Lymphoma Hodgkin Lymphoma

Start date: 2021-01-28
Primary completion: 2022-07-13
Enrollment: 358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.